Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M.J.C. van der Sangen is active.

Publication


Featured researches published by M.J.C. van der Sangen.


Ejso | 2010

Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure

F. Derkx; Adriana J. G. Maaskant-Braat; M.J.C. van der Sangen; G.A.P. Nieuwenhuijzen; L.V. van de Poll-Franse; Rudi M. H. Roumen; Adri C. Voogd

OBJECTIVE To evaluate axillary staging and management in patients with local recurrence (LR) after a previous negative sentinel lymph node biopsy (SNB). METHODS Between 1999 and 2008, 130 patients with previous negative SNB developed a LR of breast or chest wall. After examination of clinical records, 70 patients met the inclusion criteria and remained available for analysis. RESULTS Thirty-seven patients were treated with axillary lymph node dissection (ALND), followed by axillary radiotherapy in 9 cases. In 26 of these 37 patients no positive axillary lymph nodes were found. Nineteen patients received no treatment of the axilla at all. Of those, 9 were older than 70 years of age at diagnosis of LR. In 13 patients a second SNB was attempted, but was successful in only 5 cases. Eight patients underwent a complementary ALND. Overall, positive lymph nodes were detected in 13 of the 50 patients who underwent axillary staging, either by SNB or ALND. The median length of follow-up of the 70 patients following their diagnosis of LR was 24 months (range 2-81 months). During this follow-up period one patient developed an axillary recurrence. This was a patient who refused to undergo ALND but was given locoregional radiotherapy instead. CONCLUSIONS In the absence of guidelines for staging and management of the axilla at time of LR of breast or chest wall, many different strategies are being used. Considering the high rate of positive axillary lymph nodes in these patients, repeat surgical staging is appropriate.


Ejso | 2013

Effectiveness of routine follow-up in the detection of contralateral breast cancer in young women with early breast cancer

M.S. Koedijk; M.J.C. van der Sangen; Philip Poortmans; P. van Mierlo-Jansen; W.T. van den Broek; B.H.M. Storck; Adri C. Voogd

BACKGROUND The purpose of the study was to determine the effectiveness of routine follow-up to detect contralateral breast cancer (CBC) in young women. METHODS We used the data of the population-based Eindhoven Cancer Registry, which covers the southern part of the Netherlands. Between 1988 and 2005, 1451 women aged ≤ 40 years were treated for early-stage breast cancer with breast-conserving treatment or mastectomy. RESULTS Of the 94 patients who developed CBC 17 had an in situ carcinoma. Fifty-seven CBCs (61%) were diagnosed more than 5 years after the primary tumour. Forty-two CBCs (45%) were detected during routine follow-up visits, while 52 (55%) presented between two visits. Of the CBC diagnosed between two visits, only 27 (60%) were visible on mammography. Of the invasive CBCs more than 25% was larger than 2 cm in diameter and in 34% positive axillary lymph nodes were found. CONCLUSIONS These figures indicate that routine follow-up does not guarantee early detection of CBC in young women with breast cancer.


Ejso | 2006

The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma

M.J.C. van der Sangen; L.V. van de Poll-Franse; Rudi M. H. Roumen; H.J.T. Rutten; J.W.W. Coebergh; G. Vreugdenhil; Adri C. Voogd


Breast Cancer Research and Treatment | 2007

Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer

N. van den Broek; M.J.C. van der Sangen; L.V. van de Poll-Franse; M.W.P.M. van Beek; G.A.P. Nieuwenhuijzen; Adri C. Voogd


British Journal of Surgery | 2001

Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer

R. de Boer; H. F. P. Hillen; R. M. H. Roumen; H.J.T. Rutten; M.J.C. van der Sangen; Adri C. Voogd


Annals of Surgical Oncology | 2008

A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer.

L. van de Schoot; E. A. P. M. Romme; M.J.C. van der Sangen; G.J. Creemers; G. van Lijnschoten; O. J. Repelaer van Driel; H.J.T. Rutten; G.A.P. Nieuwenhuijzen


Ejso | 2005

Long-term prognosis of patients with axillary recurrence after axillary dissection for invasive breast cancer

Adri C. Voogd; S. Cranenbroek; R. de Boer; Rudi M. H. Roumen; H.J.T. Rutten; M.J.C. van der Sangen


Ejso | 2013

Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer

M.J.C. van der Sangen; Philip Poortmans; S.W.M. Scheepers; Bea martine Desiree Lemaire; C.L.H. van Berlo; V.C.G. Tjan-Heijnen; Adri C. Voogd


Annals of Surgical Oncology | 2012

Hormone Treatment without Surgery for Patients Aged 75 Years or Older with Operable Breast Cancer

C. J. Wink; K. Woensdregt; G.A.P. Nieuwenhuijzen; M.J.C. van der Sangen; S. Hutschemaekers; Jan A. Roukema; Vivianne C. G. Tjan-Heijnen; Adri C. Voogd


Ejso | 2001

Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer

A.C. Voogd; R. de Boer; M.J.C. van der Sangen; R.M.H. Roumen; H.J.T. Rutten; J.W.W. Coebergh

Collaboration


Dive into the M.J.C. van der Sangen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H.J.T. Rutten

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J.W.W. Coebergh

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Philip Poortmans

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge